Pregnancy Clinical Trial
Official title:
Effects of Pregnancy on the Physico-chemical Characteristics of Cerebrospinal Acid-base Equilibrium
The third trimester of pregnancy is typically characterized by the development of a marked
respiratory alkalosis. The possible role of pregnancy-induced variations of cerebrospinal
fluid (CSF) acid-base characteristics on the development of hypocapnic alkalosis is still
unknown.
Aim of this study is to characterize, according to Stewart's approach, the acid-base
equilibrium of CSF and arterial plasma of pregnant women and compare the results with data
obtained from fertile, non-pregnant women.
Status | Recruiting |
Enrollment | 40 |
Est. completion date | April 2019 |
Est. primary completion date | April 2019 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Pregnancy with gestational age > 35 weeks - Scheduled elective cesarean section under spinal anesthesia Exclusion Criteria: - known respiratory or neurologic disease - multiple pregnancies |
Country | Name | City | State |
---|---|---|---|
Italy | Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico | Milan |
Lead Sponsor | Collaborator |
---|---|
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | University of Milan |
Italy,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | SID PCO2 correlation | Correlation between CSF SID and PCO2 | 1 day | |
Other | Osmolality PCO2 correlation | Correlation between CSF osmolality and PCO2 | 1 day | |
Other | Plasma progesterone PCO2 correlation | Correlation between plasma progesterone concentration and plasma PCO2 | 1 day | |
Other | CSF progesterone PCO2 correlation | Correlation between CSF progesterone concentration and CSF PCO2 | 1 day | |
Primary | Strong Ion Difference | Strong Ion Difference (expressed in milliequivalents per Liter [mEq/L]) of cerebrospinal fluid and arterial plasma | 1 day | |
Secondary | Partial pressure of carbon dioxide (PCO2) | PCO2 (expressed in millimeters of Mercury [mmHg]) of cerebrospinal fluid and arterial plasma | 1 day | |
Secondary | Sum of albumin (expressed in mmol/L) and Phosphates (expressed in mmol/L) | The total amount of weak non carbonic acids, i.e. the sum of albumin and phosphates (both expressed in mmol/L) of cerebrospinal fluid and arterial plasma | 1 day | |
Secondary | Difference between cerebrospinal fluid and arterial plasma Strong Ion Difference (Delta SID) | The difference between plasma and cerebrospinal fluid SID (expressed in mEq/L) will be calculated as marker of electrolyte inbalance between these two extracellular fluid compartments. Delta SID = SIDcsf - SIDplasma | 1 day | |
Secondary | Difference between cerebrospinal fluid and arterial plasma partial pressure of CO2 (Delta PCO2) | The difference between cerebrospinal fluid and arterial plasma PCO2 (expressed in mmHg) will be calculated as a marker of acid-base equilibrium between these two extracellular fluid compartments. Delta PCO2 = SIDplasma - SIDcsf | 1 day | |
Secondary | Progesterone levels | Plasma and CSF Progesterone levels (expressed in ng/mL) will be measured | 1 day | |
Secondary | Copeptin levels | Plasma copeptin levels (expressed in pmol/L) will be measured as a marker of antidiuretic hormone activity | 1 day |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Completed |
NCT02408315 -
Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE)
|
Phase 3 |